Innovation1 Biotech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Innovation1 Biotech generated cash of -$620,195, which is more than the previous year. Cash used in financing activities reached the amount of $513,558 last year. Net change in cash is therefore -$106,637.
Cash Flow
| 2015 | -15.77K | 0 | 13.71K |
|---|---|---|---|
| 2016 | -13.00K | 0 | 17.52K |
| 2017 | -58.95K | 0 | 58.72K |
| 2018 | -442.56K | -2.46K | 1.21M |
| 2019 | -775.92K | -6.56K | 27K |
| 2020 | -410.24K | -300K | 709.15K |
| 2021 | -30.40K | 0 | 150K |
| 2022 | -3.12M | -853.13K | 4M |
| 2023 | -620.19K | 0 | 513.55K |
IVBT Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 156.48K | 137.47K | 17.88K | 18.97K | 774.46K | 25 | 5.10K | 587 | 2.64K |
Operating activities | |||||||||
Net income | -5.98M | -40.87M | 1.03M | -2.58M | -170.06K | -975.52K | -35.85K | -35.00K | -14.52K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 52.69K | 138.26K | 1.41K | 2.61K | 1.91K | 530 | 0 | 0 | 0 |
Stock-based compensation expense | 103K | 0 | 0 | 0 | 18.77K | 0 | 2 | 0 | 0 |
| Deferred income tax benefit | 103K | 0 | 0 | 0 | 18.77K | 0 | 2 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 48.52K | -56.42K | 132.85K | 67.14K | 428 | -428 | 0 | 0 | 0 |
Inventories | 0 | 56.42K | 1K | 166.11K | -150.45K | -53.11K | 0 | 0 | 0 |
Accounts payable | -248.56K | -41.52K | 132.10K | 422.51K | -10.85K | 94.18K | -21.22K | 22K | -1.25K |
Cash generated by operating activities | -620.19K | -3.12M | -30.40K | -410.24K | -775.92K | -442.56K | -58.95K | -13.00K | -15.77K |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -5 | -3.13K | 0 | 0 | -6.56K | -2.46K | 0 | 0 | 0 |
Acquisitions Net | 0 | -850K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -853.13K | 0 | -300K | -6.56K | -2.46K | 0 | 0 | 0 |
Financing activities | |||||||||
Common Stock Issued | 0 | 4M | 0 | 0 | 0 | 160K | 5K | 4.02K | 5K |
Payments for dividends | 0 | 0 | 0 | 0 | -27.28K | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -80K | 0 | 0 | 0 | -10 | 0 |
Repayments of term debt | 513.55K | 0 | -150K | -38.84K | 0 | -49.5K | 0 | -13.51K | 0 |
Cash used in financing activities | 513.55K | 4M | 150K | 709.15K | 27K | 1.21M | 58.72K | 17.52K | 13.71K |
Net Change In Cash | -106.63K | 19.01K | 119.59K | -1.09K | -755.49K | 774.44K | -231 | 4.52K | -2.05K |
Cash at end of period | 49.84K | 156.48K | 137.47K | 17.88K | 18.97K | 774.46K | 4.87K | 5.10K | 587 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |